At Phyto Life Sciences P. Ltd., research is not a department — it is a discipline that runs through every aspect of what we do. Our R&D division is the engine behind every standardized extract, every novel phytochemical, and every process improvement that reaches your formulation.
With a dedicated team of scientists, botanists, analytical chemists, and pharmacologists working in a fully equipped 1,500 sq. ft. R&D centre, we translate the intelligence of nature into commercially viable, scientifically validated ingredients.
Our R&D approach integrates multiple scientific disciplines under one roof — Ethnobotany, Pharmacognosy, Analytical Chemistry, Formulation Science, and Process Engineering. This convergence allows us to move from plant identification all the way to scaled commercial production with full scientific traceability at every stage.
Ethnobotanical records, safety data, nutritional benefits, environmental impact, sourcing feasibility, and traditional use documentation.
In vitro and in vivo activity studies, mechanism-of-action research, clinical data review, physicochemical analysis, and reference standard development.
Lab-scale to pilot-scale to commercial-scale production, followed by rigorous validation and continuous improvement cycles.
Each ingredient we develop passes through this pipeline in collaboration with recognised contract research laboratories, ensuring that every claim we make is backed by scientific evidence and reproducible methodology.
Our Phytochemistry Laboratory is dedicated to developing commercially viable extraction processes for medicinal plants where active constituents (markers) are known. Plant extracts generated through our processes are standardised to contain precisely defined quantities of biologically active components.
For plants where actives or biomarkers are yet to be characterised, our scientists undertake bioactivity-guided fractionation studies to isolate and identify key compounds for the purpose of standardisation. This capability gives our clients access to a broad ingredient portfolio that serves both the nutraceutical and pharmaceutical markets with confidence.
Accurate characterisation of botanical ingredients demands advanced analytical capability. Our Analytical R&D team works in state-of-the-art facilities designed to ensure compliance, method reliability, and international regulatory readiness.
Every analytical method we develop is designed to be reproducible, transfer-ready, and compliant with regulatory requirements — giving our B2B partners full confidence when submitting technical dossiers to health authorities.
HPLC
GCMS
HPTLC
UV-VIS
DNA
AAS / IR
Phyto Life Sciences P. Ltd. bridges the gap between raw botanical extracts and formulation-ready ingredients. Our Formulation R&D team — comprising experienced scientists, technicians, and chemists — supports the development of dosage forms that perform consistently in real-world applications.
Design and development of new dosage forms including powders, granules, and liquid concentrates.
Pre-formulation studies to assess solubility, stability, and compatibility.
Lab and pilot-scale scale-up studies.
Process optimisation and validation studies.
Technology transfer to manufacturing locations with full documentation support.
Stability testing aligned with ICH guidance for global market readiness.
Our Process R&D team works closely with manufacturing throughout the entire product lifecycle — from inception through to commercial scale-up. Our guiding principle is to ensure that all adopted processes are cost-effective, safe to handle, and optimised for yield and quality.
A key differentiator is our low-temperature extraction facility — the first of its kind — designed to match ideal cycle times, maximise the recovery of active constituents, and preserve the natural aroma, taste, and bioactivity of each ingredient.
Preserving Nature's Integrity
The system eliminates thermal degradation, ensuring that what leaves our plant is as close to nature's original composition as scientifically possible.
Efficacy begins with bioavailability. Our R&D team continually works on ADME studies — Absorption, Distribution, Metabolism, and Excretion — to understand how our phytochemicals behave once consumed. This research directly informs our particle engineering work, where scientists have successfully developed formulations that are more soluble, denser, less bitter, and lower in moisture — all of which translate directly into better end-product performance for our clients.
This expertise also underpins our Liposomal range, where botanical actives are encapsulated in phospholipid carriers to dramatically enhance cellular absorption and bioavailability.
Our R&D processes are designed to deliver batch-to-batch consistency as a non-negotiable standard. Before any new molecule or process is commercialised, our R&D and Production departments conduct a minimum of 3 to 5 consecutive production batches to verify consistency in yield, profile, and specification. Only once this consistency is demonstrated is the ingredient made available to the market.
Batch 1-2
Profile Mapping
Batch 3
Yield Verification
Batch 3-5
Validation Signoff
For supply chain teams and product developers: This standard means reliable COA parameters, predictable delivery timelines, and formulations that behave the same way every time.
